Each Osteo Gel and Emulgel merchandise include the identical energetic ingredient: diclofenac dimethylammonium gel 11.6mg/g, which acts in a non-specific method to cut back native ache and irritation wherever it’s utilized.
“Novartis and GSK’s claims, which made Osteo Gel appear simpler than Emulgel, have been unacceptable,” ACCC Commissioner Sarah Courtroom stated on Thursday.
She stated the claims have been notably regarding as a result of customers have been doubtlessly misled into paying extra for an similar product believing it was simpler.
“Voltaren Osteo Gel and Voltaren Emulgel have been basically the identical gel and have been equally efficient in treating osteoarthritis signs.”
The deceptive claims have been made on product packaging, in addition to on the Voltaren web site by each corporations.
Novartis additionally made the claims on the My Joint Well being web site.
The Arthritis Australia web site describes osteoarthritis as a situation that impacts the entire joint together with bone, cartilage, ligaments and muscular tissues and though it’s typically described as “put on and tear”, the situation is now regarded as the results of a joint working additional laborious to restore itself.
Arthritis Australia has been approached for touch upon at present’s court docket ruling.
Matt Bungard is a journalist at The Sydney Morning Herald.